Effects of cannabis regulation in Switzerland

ClinicalTrials.gov (NCT05522205). https://clinicaltrials.gov/ct2/show/NCT05522205

Alternative medicine · Cannabis · Protocol (science · Psychiatry · Randomized controlled trial · Cannabis and Cannabinoid Research · Medicine · Prenatal Substance Exposure Effects · Psychology · Sleep and related disorders · Internal Medicine · Pharmacology

• Cannabis use and its association with psychopathological symptoms in a Swiss adult population

  Open Access•Christoph Felix Mosandl, Liu YongYou et al.•Frontiers in Public Health•2024

  Añadir item

• Cannabis-Legalisierung in Kanada

  Benedikt Fischer, Tessa Robinson et al.•Monatsschrift für Kriminologie…•2025

  Añadir item

• The Züri Can study

  Open Access•Maximilian Buschner, Nadine Heckel et al.•International Journal of Drug…•2024

  Añadir item

• Thymocytes as Potential Target Cells for Nerve Growth Factor

  Open Access•Antonino Cattaneo•Molecular Aspects of Neurobiology•1986

  Añadir item

• Public health and international drug policy

  Open Access•Joanne Csete, Adeeba Kamarulzaman et al.•The Lancet•2016

  Añadir item

• The World Health Organization adult ADHD self-report scale (ASRS)

  Open Access•R C Kessler, LI Wei-l et al.•Psychological Medicine•2005

  Añadir item

• The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016

  Open Access•Louisa Degenhardt, Fiona J Charlson et al.•The Lancet Psychiatry•2018

  Añadir item

• Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016

  Magdalena Cerdá, Christine Mauro et al.•JAMA Psychiatry•2020

  Añadir item

• Public health implications of legalising the production and sale of cannabis for medicinal and recreational use

  Open Access•Wendy Hall, Wayne Hall et al.•The Lancet•2019

  Añadir item

• Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013

  Deborah S Hasin, Tulshi D Saha et al.•JAMA Psychiatry•2015

  Añadir item

• An improved brief measure of cannabis misuse

  Open Access•Simon J Adamson, Frances Kay‐Lambkin et al.•Drug and Alcohol Dependence•2010

  Añadir item

• Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016

  Open Access•Emmanuela Gakidou, Ashkan Afshin et al.•The Lancet•2017

  Añadir item

• Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis

  Arianna Marconi, Marta Di Forti et al.•Schizophrenia Bulletin•2016

  Añadir item

• Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care Population

  Open Access•Bruce Arroll, Felicity Goodyear‐Smith et al.•The Annals of Family Medicine•2010

  Añadir item

• Global burden of disease attributable to illicit drug use and dependence

  Open Access•Louisa Degenhardt, Harvey A Whiteford et al.•The Lancet•2013

  Añadir item

• Drug harms in the UK

  Open Access•David J Nutt, Leslie A King et al.•The Lancet•2010

  Añadir item

• Audit‐C as a Brief Screen for Alcohol Misuse in Primary Care

  Open Access•Katharine A Bradley, А А Шишикина et al.•Alcoholism: Clinical and…•2007

  Añadir item

• What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis

  Open Access•Janni Leung, Gary C K Chan et al.•Addictive Behaviors•2020

  Añadir item

• The Pittsburgh sleep quality index

  Open Access•Daniel J Buysse, Charles F Reynolds et al.•Psychiatry Research•1989

  Añadir item

• The Redcap consortium

  Open Access•Paul A Harris, Robert Taylor et al.•Journal of Biomedical Informatics•2019

  Añadir item

• The PHQ-9

  Kurt Kroenke, Robert L Spitzer et al.•Journal of General Internal…•2001

  Añadir item

• Measuring change in cannabis use

  Simon J Adamson, Frances Kay‐Lambkin et al.•Addiction Research & Theory•2014

  Añadir item

• Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use

  Open Access•Benedikt Fischer, Tessa Robinson et al.•International Journal of Drug…•2022

  Añadir item

• Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population

  Bernd Löwe, Oliver Decker et al.•Medical Care•2008

  Añadir item